J. M. Adams and S. Cory (1998). The Bcl-2 protein family: Arbiters of cell survival. Science
Y. Tsujimoto, L. R. Finger, J. Yunis, P. C. Nowell, and C. M. Croce (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science
S. J. Korsmeyer (1992). Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood
T. J. McDonnell and S. J. Korsmeyer (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature
Z. N. Oltvai and S. J. Korsmeyer (1994). Checkpoints of dueling dimers foil death wishes [comment]. Cell
G. T. Williams and C. A. Smith (1993). Molecular regulation of apoptosis: Genetic controls on cell death. Cell
S. J. Korsmeyer (1995). Regulators of cell death. Trends Genet
X. M. Yin, Z. N. Oltvai, and S. J. Korsmeyer (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [see comments]. Nature
T. Chittenden, C. Flemington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz (1995). A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J.
D. T. Chao and S. J. Korsmeyer (1998). BCL-2 family: Regulators of cell death. Ann. Rev. Immunol.
S. J. Korsmeyer, J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol.
W. Zhu, A. Cowie, G. W. Wasfy, L. Z. Penn, B. Leber, and D. W. Andrews (1996). Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J.
H. Zha, H. A. Fisk, M. P. Yaffe, N. Mahajan, B. Herman, and J.:C. Reed (1996). Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell Biol.
D. R. Green and J. C. Reed (1998). Mitochondria and apoptosis. Science
J. C. Reed (1997). Double identity for proteins of the Bcl-2 family. Nature
R. M. Kluck, E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science
J. Yang, X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science
X. Liu, C. N. Kim, J. Yang, R. Jemmerson, and X. Wang (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell
T. Rosse, R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner (1998). Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature
J. Zha, H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3–3 not BCL-X(L). Cell
E. Yang, J. Zha, J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer (1995). Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell
S. Haldar, N. Jena, and C. M. Croce (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U.S.A.
S. Takayama, T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed (1995). Cloning and functional analysis of BAG-1: A novel Bcl-2–binding protein with anti-cell death activity. Cell
S. Takayama, D. N. Bimston, S. Matsuzawa, B. C. Freeman, C. Aime-Sempe, Z. Xie, R. I. Morimoto, and J. C. Reed (1997). BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J.
G. Pan, K. O'Rourke, and V. M. Dixit (1998). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem.
L. A. O'Reilly, D. C. Huang, and A. Strasser (1996). The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J.
D. C. Huang, L. A. O'Reilly, A. Strasser, and S. Cory (1997). The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J.
W. S. el-Deiry, J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, and Y. Wang (1994). WAF1/CIP1 is induced in p53–mediated G1 arrest and apoptosis. Cancer Res.
C. Borner (1996). Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem.
E. J. Uhlmann, C. D'Sa-Eipper, T. Subramanian, A. J. Wagner, N. Hay, and G. Chinnadurai (1996). Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation. Cancer Res.
G. Gil-Gomez, A. Berns, and H. J. Brady (1998). A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J.
G. P. Linette, Y. Li, K. Roth, and S. J. Korsmeyer (1996). Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. U.S.A.
P. A. Furth, U. Bar-Peled, M. Li, A. Lewis, R. Laucerica, R. Jager, H. Weiher, and R. Russell (1999). Loss of anti-mitotic activity of Bcl-2 with retention of anti-apoptotic function during tumor progression in a mouse model. (Submitted).
K. L. Murphy, F. S. Kittrell, J. P. Gay, R. Jaeger, D. Medina, and J. M. Rosen (1999). Bcl-2 expression inhibits mammary tumor development in dimethylbenz(a) anthracene-treat ed transgenic mice. (Submitted).
R. C. Humphreys (1999). Programmed cell death in the terminal endbud. J. Mam. Gland Biol. Neoplasia
R. C. Humphreys, M. Krajewska, S. Krnacik, R. Jaeger, H. Weiher, S. Krajewski, J. C. Reed, and J.M. Rosen (1996). Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development
K. Heermeier, M. Benedict, M. Li, P. Furth, G. Nunez, and L. Hennighausen (1996). Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech. Dev.
S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci.
R. C. Bargou, P. T. Daniel, M. Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H. D. Royer, and B. Dorken (1995). Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer
J. M. Gee, J. F. Robertson, I. O. Ellis, P. Willsher, R. A. McClelland, H. B. Hoyle, S. R. Kyme, P. Finlay, R. W. Blamey, and R. I. Nicholson (1994). Immunocytochem ical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer
G. J. Zhang, I. Kimijima, A. Tsuchiya, and R. Abe (1998). The role of bcl-2 expression in breast carcinomas (Review). Oncol. Rep.
M. Li, J. Hu, K. Heermeier, L. Hennighausen, and P. A. Furth (1996). Expression of a viral oncoprotein during mammary gland development alters cell fate and function: Induction of p53–independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Differ. 7: 3–11.
M. Li, J. Hu, K. Heermeier, L. Hennighausen, and P. A. Furth (1996). Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53–independent pathways. Cell Growth Differ. 7:13–20.
A. Sierra, X. Castellsague, T. Coll, S. Manas, A. Escobedo, A. Moreno, and A. Fabra (1998). Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. Int. J. Cancer
S. Kitada, M. Krajewska, X. Zhang, D. Scudiero, J. M. Zapata, H. G. Wang, A. Shabaik, G. Tudor, S. Krajewski, T. G. Myers, G. S. Johnson, E. A. Sausville, and J. C. Reed (1998). Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol.
J. M. Zapata, M. Krajewska, S. Krajewski, R. Huang, S. Takayama, H. G. Wang, E. Adamson, and J. C. Reed (1998). Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res. Treat.
C. V. Clevenger, K. Thickman, W. Ngo, W. P. Chang, S. Takayama, and J. C. Reed (1997). Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol. Endocrinol.
H. G. Wang, S. Takayama, U. R. Rapp, and J. C. Reed (1996). Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. U.S.A.
S. Krajewski, M. Krajewska, A. Shabaik, H. G. Wang, S. Irie, L. Fong, and J. C. Reed (1994). Immunohistoche mical analysis of in vivo patterns of Bcl-X expression. Cancer Res.
D. M. Hockenbery, M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer (1991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A.
S. Takayama, S. Krajewski, M. Krajewska, S. Kitada, J. M. Zapata, K. Kochel, D. Knee, D. Scudiero, G. Tudor, G. J. Miller, T. Miyashita, M. Yamada, and J. C. Reed (1998). Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res.
S. Krajewski, M. Krajewska, A. Shabaik, T. Miyashita, H. G. Wang, and J. C. Reed (1994). Immunohistochem ical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol.
N. Motoyama, F. Wang, K. A. Roth, H. Sawa, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, and S. Fujii (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science
A. Ma, J. C. Pena, B. Chang, E. Margosian, L. Davidson, F. W. Alt, and C. B. Thompson (1995). Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. U.S.A.
S. Kamada, A. Shimono, Y. Shinto, T. Tsujimura, T. Takahashi, T. Noda, Y. Kitamura, H. Kondoh, and Y. Tsujimoto (1995). Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentati on, and distorted small intestine. Cancer Res.
D. J. Veis, C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer (1993). Bcl-2–deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell
V. S. Ratts, J. A. Flaws, R. Kolp, C. M. Sorenson, and J. L. Tilly (1995). Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology
T. M. Michaelidis, M. Sendtner, J. D. Cooper, M. S. Airaksinen, B. Holtmann, M. Meyer, and H. Thoenen (1996). Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron
K. Nakayama, I. Negishi, K. Kuida, H. Sawa, and D. Y. Loh (1994). Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. U.S.A.
K. Nakayama, I. Negishi, K. Kuida, Y. Shinkai, M. C. Louie, L. E. Fields, P. J. Lucas, V. Stewart, and F. W. Alt (1993). Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science
T. L. Deckwerth, J. L. Elliott, C. M. Knudson, E. M. Johnson, Jr., W. D. Snider, and S. J. Korsmeyer (1996). BAX is required for neuronal death after trophic factor deprivation and during development. Neuron
F. A. White, C. R. Keller-Peck, C. M. Knudson, S. J. Korsmeyer, and W. D. Snider (1998). Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci.
C. M. Knudson, K. S. Tung, W. G. Tourtellotte, G. A. Brown, and S. J. Korsmeyer (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science
C. G. Print, K. L. Loveland, L. Gibson, T. Meehan, A. Stylianou, N. Wreford, D. de Kretser, D. Metcalf, F. Kontgen, J. M. Adams, and S. Cory (1998). Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant [In process citation]. Proc. Natl. Acad. Sci. U.S.A.
A. J. Ross, K. G. Waymire, J. E. Moss, A. F. Parlow, M. K. Skinner, L. D. Russell, and G. R. MacGregor (1998). Testicular degeneration in Bclw-deficient mice [see comments]. Nat. Genet.
K. Schorr, U. Bar-Peled, M. Li, A. Lewis, A. Heredia, B. Lewis, C. M. Knudson, S. J. Korsmeyer, R. Jager, H. Weiher, and P. A. Furth, (1999). Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival during tissue remodeling, Cancer Research: (in press).
K. U. Wagner, R. J. Wall, L. St-Onge, P. Gruss, A. Wynshaw-Boris, L. Garrett, M. Li, P. A. Furth, and L. Hennighausen (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res.
J. Rodriguez-Villanueva, D. Greenhalgh, X. J. Wang, D. Bundman, S. Cho, M. Delehedde, D. Roop, and T. J. McDonnell (1998). Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene
P. Naik, J. Karrim, and D. Hanahan (1996). The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10:2105–2116.
R. Jager, U. Herzer, J. Schenkel, and H. Weiher (1997). Over-expression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene
C. Teixeira, J. C. Reed, and M. A. Pratt (1995). Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res.
T. T. Wang and J. M. Phang (1995). Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res.
Y. Huang, S. Ray, J. C. Reed, A. M. Ibrado, C. Tang, A. Nawabi, and K. Bhalla (1997). Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat.
D. Delia, A. Aiello, D. Soligo, E. Fontanella, C. Melani, F. Pezzella, M. A. Pierotti, and G. Della Porta (1992). bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood
J. C. Reed (1996). Balancing cell life and death: Bax, apoptosis, and breast cancer [editorial; comment]. J. Clin. Invest.
J. C. Reed (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol.
S. Krajewski, C. Blomqvist, K. Franssila, M. Krajewska, V. M. Wasenius, E. Niskanen, S. Nordling, and J.C. Reed (1995). Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res.
A. Marti, Z. Feng, B. Jehn, V. Djonov, G. Chicaiza, H. J. Altermatt, and R. Jaggi (1995). Expression and activity of cell cycle regulators during proliferation and programmed cell death in the mammary gland. Cell Death Differ
P. Lipponen, T. Pietilainen, V. M. Kosma, S. Aaltomaa, M. Eskelinen, and K. Syrjanen (1995). Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favorable prognosis. J. Pathol.
S. W. Lowe, H. E. Ruley, T. Jacks, and D. E. Housman (1993). p53–dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell
L. R. Lund, J. Romer, N. Thomasset, H. Solberg, C. Pyke, M. J. Bissell, K. Dano, and Z. Werb (1996). Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and-dependent pathways. Development
R. C. Bargou, C. Wagener, K. Bommert, M. Y. Mapara, P. T. Daniel, W. Arnold, M. Dietel, H. Guski, A. Feller, H. D. Royer, and B. Dorken (1996). Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice [see comments]. J. Clin. Invest.
C. M. Knudson and S. J. Korsmeyer (1997). Bcl-2 and Bax function independently to regulate cell death. Nat. Genet.
C. Yin, C. M. Knudson, S. J. Korsmeyer, and T. Van Dyke (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature
R. Bernard, S. Dieni, S. Rees, and O. Bernard (1998). Physiological and induced neuronal death are not affected in NSE-bax transgenic mice. J. Neurosci. Res.
P. G. Farlie, R. Dringen, S. M. Rees, G. Kannourakis, and O. Bernard (1995). bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. U.S.A.
J. C. Martinou, M. Dubois-Dauphin, J. K. Staple, I. Rodriguez, H. Frankowski, M. Missotten, P. Albertini, D. Talabot, S. Catsicas, and C. Pietra (1994). Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron
M. Dubois-Dauphin, H. Frankowski, Y. Tsujimoto, J. Huarte, and J. C. Martinou (1994). Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. U.S.A.
D. A. Grillot, R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Nunez (1996). Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med.
D. A. Grillot, R. Merino, and G. Nunez (1995).Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med.
J. C. Reed, S. Krajewski, S. Kitada, and T. Miyashita (1998) Methods of measuring Bcl-2 gene expression. In Handbook of Experimental Immunology, Ed. Herzenberg and Weir Blackwell Science, Cambridge.
S. Krajewski, A. Hugger, M. Krajewska, J. C. Reed, and J. K. Mai (1998). Developmental expression patterns of Bcl-2, Bcl-x, Bax, and Bak in teeth. Cell Death Differ. 5: 408–415.